Search results for "Cytiva" in Articles / App Notes
Article
Navigating Molecular Diversity
Are you working with biomolecules beyond mAbs?
Read more here >>
Article
Mechanistic vs Statistical Models
Mathematical models are recommended by the ICH Q8 guidelines on pharmaceutical development to generate enhanced process understanding and meet Quality-by-Design (QbD) guidelines. Read on the d…
Article
Discover new ways to improve buffer preparation
Large quantities of buffers are needed throughout the biomanufacturing process. Most biomanufacturers are still preparing their buffers manually, tying up significant resources, but there are b…
Article
Mechanistic chromatography models in a nutshell
Find out how mechanistic modeling simulates what happens in your chromatography columns.
Watch the animation >>
Article
Recent Trends in Data Analytics for Upstream Process Workflows
Modeling techniques can improve process control and monitoring in biopharmaceutical production.
Read more about it here >>
Article
Emerging biopharma: progressing a biologic drug to market
There are many pitfalls in the road to developing and bringing a new therapy to market. Understanding some of these areas and being prepared to make the right decisions at the right ti…
Article
Moving beyond automation - next industrial revolution is digital
Experts expect Industry 4.0 to trigger a quantum leap in productivity. Connected machines and software systems can enhance the human workforce, minimize maintenance downtime and spare …
Article
Digital transformation of biopharmaceutical process development
Digital transformation has become an increasingly important topic for the biopharmaceutical industry as it leads to new opportunities for additional value creation and competitiv…
Article
Enhancing Resins Addresses Purification Concerns
…s, and virus like particles, notes Henrik Ihre, PhD, director of Strategic Technology Partnerships, Cytiva. Ihre explains that no one unique purification protocol can be applied to all these modaliti…
Article
The Pulse on the Industry - BioPlan and the Biopharma Resilience Index
This podcast is an informative and accessible discussion on the biopharma industry’s needs and possible solutions being taken to address these issues.
LISTEN TO THE PODCAST >